May 19, 2024
Home FDA
Finance

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

  • May 10, 2024

Checkpoint Therapeutics, Inc WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2024, and recent corporate updates. James F. Oliviero, President and Chief Executive Officer of Checkpoint, said, “Over the past few

Read More
Funds

Federal funds coming to New Hampshire to address PFAS concerns

  • April 10, 2024

New Hampshire will be getting nearly $10 million in federal funding to address concerns about PFAS chemicals in water.The Biden administration announced Wednesday that $1 billion in federal money will be put toward detection and treatment systems as part of new national drinking water standards. PFAS, short for per- and polyfluoroalkyl substances, are a class

Read More